oxycodone has been researched along with Cancer of Stomach in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, XY; Huang, ZK; Pu, J; Wang, N; Yuan, HB | 1 |
| Chen, X; Hu, J; Li, K; Liu, F; Liu, K; Song, X; Yang, K; Zhang, W | 1 |
| Bruera, E; Kang, JH; Lee, GW; Shin, SH | 1 |
| Liu, C; Ruan, XJ; Yu, ZH; Zhang, X | 1 |
| Huang, XE; Li, CG; Li, Y; Lu, YY | 1 |
| Araki, N; Hasegawa, H; Hatanaka, K; Hiraga, K; Katayama, K; Kawahara, M; Kimura, H; Kodama, K; Koizumi, W; Kono, I; Matsui, K; Takeda, F; Takiuchi, H; Toma, H; Watanabe, K; Yoshino, K | 1 |
2 trial(s) available for oxycodone and Cancer of Stomach
| Article | Year |
|---|---|
[Effect of vaginal administration of controlled-release oxycodone on cancer pain].
Topics: Administration, Intravaginal; Adult; Aged; Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Delayed-Action Preparations; Female; Humans; Lung Neoplasms; Middle Aged; Oxycodone; Pain; Stomach Neoplasms | 2009 |
Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Oxycodone; Pain Measurement; Pain, Intractable; Patient Acceptance of Health Care; Stomach Neoplasms; Tablets; Titrimetry | 2004 |
4 other study(ies) available for oxycodone and Cancer of Stomach
| Article | Year |
|---|---|
Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer.
Topics: Analgesics, Opioid; Female; Genotype; Humans; Injections, Intravenous; Intestinal Neoplasms; Laparoscopes; Male; Middle Aged; Oxycodone; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Stomach Neoplasms; Sufentanil | 2019 |
[Application of multimodal analgesia in radical gastrectomy for gastric cancer patients: a prospective nonrandomized controlled study].
Topics: Acetaminophen; Amides; Analgesia, Patient-Controlled; China; Comparative Effectiveness Research; Defecation; Drug Combinations; Eating; Flatulence; Gastrectomy; Humans; Isoxazoles; Length of Stay; Oxycodone; Pain Management; Pain, Postoperative; Postoperative Complications; Prospective Studies; Recovery of Function; Ropivacaine; Stomach Neoplasms; Surgical Wound; Suture Techniques; Treatment Outcome; Walking | 2017 |
Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.
Topics: Abdominal Pain; Analgesics, Opioid; Delayed-Action Preparations; Female; Humans; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Oxycodone; Portal Vein; Stomach Neoplasms; Substance Withdrawal Syndrome; Treatment Outcome; Venous Thrombosis | 2013 |
Clinical observations on safety and efficacy of OxyContin® administered by rectal route in treating cancer related pain.
Topics: Administration, Rectal; Analgesics, Opioid; Bone Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Oxycodone; Pain; Pain Management; Pain Measurement; Stomach Neoplasms | 2011 |